Monitor the September 16 fireside chat for any clinical updates or pipeline commentary that could move the stock. No immediate trading action warranted based on this filing alone.
Price Chart
Executive Summary
Helus Pharma (Cybin Inc.) announced CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026. This is a routine investor relations event with no material financial data, clinical results, or guidance provided. The filing is non-substantive and does not alter the company's fundamental outlook.
Key Facts
- CEO Michael Halstead to speak at Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026
- Fireside chat will be webcast live at 8:30 a.m. EDT
- No financial results, clinical data, or guidance were disclosed in this filing
- HLP003 is in Phase 3 for major depressive disorder with FDA Breakthrough Therapy Designation
- HLP004 is in Phase 2 for generalized anxiety disorder
Financial Impact
No financial impact — routine conference participation announcement with no material data
Risk Factors
- No new clinical or financial data — stock may not react to this routine event
- Forward-looking statements in the release carry standard clinical and regulatory risks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001833141-26-000074 |
| Document: cybininc-form6xk09x10x2026.htm | 0001833141-26-000074 |
| Document: 0001833141-26-000074-index-headers.html | 0001833141-26-000074 |
| Document: 0001833141-26-000074-index.html | 0001833141-26-000074 |
| Document: 0001833141-26-000074.txt | 0001833141-26-000074 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 3 | $10.11 | awaiting T+20 | — | $10.36 (+2.47%) |
Oct 26, 2026 today | 3 | $10.86 | awaiting T+20 | — | $10.36 (−4.56%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 21, 2026 5d ago | 6-K | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 15, 2026 11d ago | 6-K | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
Oct 15, 2026 11d ago | Press Release | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
Oct 8, 2026 18d ago | 6-K | $10.72 | awaiting T+20 | — | $10.36 (−3.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers